These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30791148)

  • 21. Early Differentiation of Human CD11c
    Ramírez-Ramírez D; Vadillo E; Arriaga-Pizano LA; Mayani H; Estrada-Parra S; Velasco-Velázquez MA; Pérez-Tapia SM; Pelayo R
    J Immunol Res; 2016; 2016():4097642. PubMed ID: 27847830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow.
    Manzke O; Berthold F; Huebel K; Tesch H; Diehl V; Bohlen H
    Int J Cancer; 1999 Mar; 80(5):715-22. PubMed ID: 10048973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Normal Hematopoietic Stem and Progenitor Cell Contents in Childhood Acute Leukemia Bone Marrow.
    Balandrán JC; Vadillo E; Dozal D; Reyes-López A; Sandoval-Cabrera A; Laffont-Ortiz MD; Prieto-Chávez JL; Vilchis-Ordoñez A; Quintela-Nuñez Del Prado H; Mayani H; Núñez-Enríquez JC; Mejía-Aranguré JM; López-Martínez B; Jiménez-Hernández E; Pelayo R
    Arch Med Res; 2016 Nov; 47(8):629-643. PubMed ID: 28476191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease.
    Vicente López Á; Vázquez García MN; Melen GJ; Entrena Martínez A; Cubillo Moreno I; García-Castro J; Orellana MR; González AG
    PLoS One; 2014; 9(1):e84496. PubMed ID: 24400095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-associated alterations in marrow T cells in pediatric leukemia.
    Bailur JK; McCachren SS; Pendleton K; Vasquez JC; Lim HS; Duffy A; Doxie DB; Kaushal A; Foster C; DeRyckere D; Castellino S; Kemp ML; Qiu P; Dhodapkar MV; Dhodapkar KM
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32692727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
    Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
    Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.
    Costello RT; Sivori S; Mallet F; Sainty D; Arnoulet C; Reviron D; Gastaut JA; Moretta A; Olive D
    Leukemia; 2002 May; 16(5):855-60. PubMed ID: 11986947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
    Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
    Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
    Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
    Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
    Jinushi M; Takehara T; Tatsumi T; Kanto T; Miyagi T; Suzuki T; Kanazawa Y; Hiramatsu N; Hayashi N
    J Immunol; 2004 Nov; 173(10):6072-81. PubMed ID: 15528343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia.
    Yang F; Wang R; Feng W; Chen C; Yang X; Wang L; Hu Y; Ren Q; Zheng G
    Mol Immunol; 2018 Jan; 93():68-78. PubMed ID: 29154208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.
    Sørskaar D; Førre O; Lie SO
    Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.
    Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D
    J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
    Duault C; Kumar A; Taghi Khani A; Lee SJ; Yang L; Huang M; Hurtz C; Manning B; Ghoda L; McDonald T; Lacayo NJ; Sakamoto KM; Carroll M; Tasian SK; Marcucci G; Yu J; Caligiuri MA; Maecker HT; Swaminathan S
    Blood; 2021 Oct; 138(16):1465-1480. PubMed ID: 34077953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape].
    Catros V; Dessarthe B; Thedrez A; Toutirais O
    Med Sci (Paris); 2014 May; 30(5):537-43. PubMed ID: 24939541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition of unusual presentation of natural killer cell leukemia.
    Gardiner CM; Reen DJ; O'Meara A
    Am J Hematol; 1995 Oct; 50(2):133-9. PubMed ID: 7572992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche.
    Müller LME; Migneco G; Scott GB; Down J; King S; Askar B; Jennings V; Oyajobi B; Scott K; West E; Ralph C; Samson A; Ilett EJ; Muthana M; Coffey M; Melcher A; Parrish C; Cook G; Lawson M; Errington-Mais F
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD56-positive acute lymphoblastic leukemia.
    Matano S; Terahata S; Nakamura S; Kobayashi K; Sugimoto T
    Acta Haematol; 2005; 114(3):160-3. PubMed ID: 16227680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.